American Capital Advisory, LLC Biogen Inc. Call Options Transaction History
American Capital Advisory, LLC
- $172 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BIIB
# of Institutions
1,022Shares Held
126MCall Options Held
1.18MPut Options Held
1.36M-
Vanguard Group Inc Valley Forge, PA16.7MShares$2.77 Billion0.06% of portfolio
-
Primecap Management CO Pasadena, CA16.3MShares$2.7 Billion2.37% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.41 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.1MShares$1.18 Billion0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.68MShares$941 Million0.83% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $23.9B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...